Experimental cancer drug trial halted early
NCT ID NCT06974734
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This early-stage study tested a new drug, PF-08046037, alone or with another drug (sasanlimab) in people with advanced lung, head and neck, skin, or pancreatic cancers. The goal was to check safety and how the body processes the drug. Only 8 people took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Community Health Network, Inc
Indianapolis, Indiana, 46219, United States
-
Community Health Network, Inc.
Indianapolis, Indiana, 46227, United States
-
Community Health Network, Inc.
Indianapolis, Indiana, 46250, United States
-
Community Health Network, Inc.
Indianapolis, Indiana, 46256, United States
-
Pan American Center for Oncology Trials, LLC
Rio Piedras, 00935, Puerto Rico
-
Presbyterian/ St. Lukes Medical Center
Denver, Colorado, 80218, United States
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
START Midwest
Grand Rapids, Michigan, 49546, United States
-
Sarah Cannon Research Institute - Pharmacy
Nashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute at HealthONE
Denver, Colorado, 80218, United States
-
Smilow Cancer Hospital - Trumbull
Trumbull, Connecticut, 06611, United States
-
Smilow Cancer Hospital - Yale New Haven Health
New Haven, Connecticut, 06510, United States
-
Smilow Cancer Hospital Phase 1 Unit
New Haven, Connecticut, 06511, United States
-
Tristar Centennial Medical Center
Nashville, Tennessee, 37203, United States
-
Yale - New Haven Hospital - Yale Cancer Center
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.